Concepedia

Author

Timothy Reid

Sisters of Mercy Health System

Also Known As

Reid, T Reid, T. Reid, TIMOTHY REID, TIMOTHY S. REID, Timothy Reid, Timothy S Reid, Timothy S. Reid

47

Publications

365

Citations

10

H-Index

11

Concepts

All Affiliations

Sisters of Mercy Health SystemSanofi (United States)Sanofi (France)
TR

About

Timothy Reid is an author at Sisters of Mercy Health System specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

78

2

Pharmacology

2

2

78

3

Diabetes

1

1

43

4

Clinical Pharmacology

1

1

35

5

Clinical Trials

1

1

35

Timothy Reid

×

8

Publications

229

Citations

8

H-Index

YearCitations

How much is too much? Outcomes in patients using high‐dose insulin glargine

Timothy Reid, Ling Gao, Jesjeet Singh Gill,

International Journal of Clinical Practice

2015

45

Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Primary Care

Timothy Reid

Clinical Diabetes

2013

43

Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence

Timothy Reid

Clinical Diabetes

2012

35

Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers

Louis Kuritzky, Timothy Reid, Carol Wysham

Clinical Diabetes

2019

32

Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables

Tricia Santos Cavaiola, Yan Kiriakov, Timothy Reid

Clinical Therapeutics

2019

30

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes

Charles F. Shaefer, Timothy Reid, George Dailey,

Postgraduate Medicine

2014

18

Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes

Fang Liz Zhou, Jason Yeaw, Swapna Karkare,

BMJ Open Diabetes Research & Care

2018

15

A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes

J. Hans DeVries, Luigi Meneghini, Anthony Barnett,

touchREVIEWS in Endocrinology

2014

11

Page 1